Skip to main content

Table 2 Genes that reached or approached exome-wide significance in the Fuwai DCM HTx cohort

From: Genetic characterization of dilated cardiomyopathy patients undergoing heart transplantation in the Chinese population by whole-exome sequencing

 

No. of patients in DCM cases (208)

No. of patients in the reference group (568)

CMC

Fp

SkatO

Zeggini

Truncating + nontruncating

TTN

66

84

3.90E−07

3.06E−09

9.66E−08

3.17E−08

FLNC

32

12

7.38E−13

4.08E−13

2.15E−10

6.73E−13

LMNA

9

3

6.35E05

4.25E−06

1.44E−05

3.07E−05

BAG3

7

0

1.05E−05

1.59E−05

2.64E−05

1.05E−05

Truncating variants

TTN

39

11

1.66E−15

1.22E−15

2.15E−10

1.64E−14

FLNC

18

0

9.24E−13

3.98E−12

2.23E−10

9.24E−13

LMNA

4

0

1.21E−03

2.91E−03

5.24E−03

1.21E−03

BAG3

6

0

3.71E−05

5.49E−05

8.03E−05

3.71E−05

Nontruncating variants

TTN

38

74

5.95E−02

8.09E−02

1.60E−01

7.79E−02

FLNC

16

12

1.76E−04

2.37E−04

3.34E−04

1.76E−04

LMNA

5

3

1.06E−02

2.23E−03

7.19E−03

4.44E−03

BAG3

1

0

1.22E−01

1.22E−01

1.22E−01

1.22E−01

  1. Burden analysis was performed via four test models (CMC, Fp, SkatO, and Zeggini) in DCM cases and the reference group, and a P value ≤ 6.1 × 10–6 (Bonferroni correction for 8226 genes), which is marked in bold, indicated a statistically significant difference
  2. DCM dilated cardiomyopathy, TTN titin, FLNC filamin C, LMNA lamin A/C, BAG3 BAG cochaperone 3